Irritable bowel syndrome treatment market was valued at $1,071 million in 2018, and is estimated to reach at $2,012 million by 2026, registering a CAGR of 8.2% from 2019 to 2026.
Irritable bowel syndrome is a gastrointestinal disorder of gut that may be identified by colon muscle contraction. It majorly affects the large intestine. In addition, it is associated with the malfunction of the bowel, and majorly occurs in geriatric population. Diarrhea, constipation, alteration & discomfort in bowel function, bloating, and abdominal pain are some of the common symptoms of irritable bowel syndrome. Endoscopy and blood test are normally performed to detect this irritable bowel syndrome. Irritable bowel syndrome is classified into three types such as IBS with diarrhea (IBS-D), IBS with constipation (IBS-C), and mixed IBS. Treatment of irritable bowel syndrome include proper medicines, change in diet, stress relief, and counseling. Medicines used in the treatment of irritable bowel syndrome include rifaximin, eluxadoline, lubiprostone, linaclotide, and others.
Major Key Players of the Irritable Bowel Syndrome Treatment Market are:
Abbott Laboratories, Allergan plc, Ardelyx Inc., Astellas Pharma Inc., AstraZeneca plc, GlaxoSmithKline Plc, Johnson & Johnson (McNeil Consumer Healthcare), Novartis AG, Sebela Pharmaceuticals Inc., Takeda Pharmaceutical Company Ltd.
Download PDF to Know the Impact of COVID-19 on “Irritable Bowel Syndrome Treatment Market” at: https://www.marketgrowthinsight.com/sample/83802?source=shubh
Significant increase in prevalence of gastrointestinal diseases and disorders such as alteration of bowel habit, abdominal pain, adoption of sedentary lifestyle, increase in level of stress, and unhealthy diet are the key factors that fuel the growth of the irritable bowel syndrome treatment market. According to the International Foundation for Gastrointestinal Disorders (IFFGD), it was estimated that irritable bowel syndrome affects around 25-45 million in the U.S. in 2016. Moreover, company developing products with symptom specific application and subsequent launches, increase in geriatric population, and rise in awareness programs for irritable bowel syndrome treatment are other factors that contribute toward the growth of the market. Furthermore, rise in prevalence of irritable bowel syndrome in female is expected to further boost the growth of global irritable bowel treatment market during the forecast period. However, high competition among the key players related to pricing and lack of specific treatment which treat all the symptoms of this disorder are expected to hinder the growth of the market.
The Irritable Bowel Syndrome Treatment is segmented on the basis of Type, Product, End User and region.
Major Types of Irritable Bowel Syndrome Treatment Market covered are:
- IBS with Diarrhea (IBS-D)
- IBS with Constipation (IBS-C)
- Mixed IBS
Major Product of Irritable Bowel Syndrome Treatment Market covered are:
- Rifaximin
- Eluxadoline
- Lubiprostone
- Linaclotide
- Others
Major End User of Irritable Bowel Syndrome Treatment Market covered are:
- Hospitals Pharmacies
- Drug Stores & Retail Pharmacies
- Online Pharmacies
Research objectives:-
– To study and analyze the global Irritable Bowel Syndrome Treatment consumption (value & volume) by key regions/countries, product type and application, history data.
– To understand the structure of the Irritable Bowel Syndrome Treatment market by identifying its various sub-segments.
– Focuses on the key global Irritable Bowel Syndrome Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.
– To analyze the Irritable Bowel Syndrome Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
– To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Have any query? Inquiry about report at: https://www.marketgrowthinsight.com/inquiry/83802?source=shubh
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.5 Market by Application
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Irritable Bowel Syndrome Treatment Market Size
2.2 Irritable Bowel Syndrome Treatment Growth Trends by Regions
2.3 Industry Trends
3 Market Share by Key Players
3.1 Irritable Bowel Syndrome Treatment Market Size by Manufacturers
3.2 Irritable Bowel Syndrome Treatment Key Players Head office and Area Served
3.3 Key Players Irritable Bowel Syndrome Treatment Product/Solution/Service
3.4 Date of Enter into Irritable Bowel Syndrome Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Irritable Bowel Syndrome Treatment Sales by Product
4.2 Global Irritable Bowel Syndrome Treatment Revenue by Product
4.3 Irritable Bowel Syndrome Treatment Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Irritable Bowel Syndrome Treatment Breakdown Data by End User
Buy Exclusive Report @ https://www.marketgrowthinsight.com/checkout/83802?source=shubh
In the end, Irritable Bowel Syndrome Treatment industry report specifics the major regions, market scenarios with the product price, volume, supply, revenue, production, and market growth rate, demand, forecast and so on. This report also presents SWOT analysis, investment feasibility analysis, and investment return analysis.
About Us-
Market Growth Insight 100% Subsidiary of Exltech Solutions India, is a one stop solution for market research reports in various business categories. We are serving 100+ clients with 30000+ diverse industry reports and our reports are developed to simplify strategic decision making, on the basis of comprehensive and in-depth significant information, established through wide ranging analysis and latest industry trends.
Contact Us-
Email: sales@marketgrowthinsight.com
Phone: + 91 8956767535
Website: https://www.marketgrowthinsight.com
